BMI1 as oncogenic candidate in a novel TCRB-associated chromosomal aberration in a patient with TCRgammadelta+ T-cell acute lymphoblastic leukemia.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Leukemia

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 17989714
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular cytogenetic study of 126 unselected T-ALL cases reveals high incidence of TCRβ locus rearrangements and putative new T-cell oncogenes

  2006cited by this paper
• Recombinase, chromosomal translocations and lymphoid neoplasia: targeting mistakes and repair failures.

  2006cited by this paper
• Role of Polycomb Group Proteins in Stem Cell Self-Renewal and Cancer

  2005cited by this paper
• Disruption of the BCL11B gene through inv(14)(q11.2q32.31) results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL

  2005cited by this paper
• HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL).

  2005cited by this paper
• CALM-AF10+ T-ALL expression profiles are characterized by overexpression of HOXA and BMI1 oncogenes

  2005cited by this paper
• Immunophenotypic and immunogenotypic characteristics of TCRgammadelta+ T cell acute lymphoblastic leukemia.

  1999cited by this paper
• Detection of T cell receptor beta (TCRB) gene rearrangement patterns in T cell malignancies by Southern blot analysis

  1999cited by this paper

• cell receptor ( TCR ) and non-TCR associated aberrations in T-cell acute lymphoblastic leukemia

  2019cites this paper
• Mechanisms of acute leukemia disease initiation and maintenance through manipulation of IGF1R and RUNX family members.

  2017cites this paper
• High BMI1 mRNA expression in peripheral whole blood is associated with favorable prognosis in advanced non-small cell lung cancer patients

  2017cites this paper
• Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBPα expression

  2016cites this paper
• miR-203 inhibits cell growth and regulates G1/S transition by targeting Bmi-1 in myeloma cells.

  2016cites this paper
• ShRNA-mediated Bmi-1 silencing sensitizes multiple myeloma cells to bortezomib.

  2014cites this paper
• Breakpoint sites disclose the role of the V(D)J recombination machinery in the formation of T-cell receptor (TCR) and non-TCR associated aberrations in T-cell acute lymphoblastic leukemia

  2013cites this paper
• BMI1 Sustains Human Glioblastoma Multiforme Stem Cell Renewal

  2009cites this paper
• Copy number alterations of the polycomb gene BMI1 in gliomas

  2008cites this paper